Skip to main content
. Author manuscript; available in PMC: 2023 Sep 28.
Published in final edited form as: J Community Health. 2023 Mar 10;48(4):640–651. doi: 10.1007/s10900-023-01202-y

Table 2.

Characteristics of the study sample (N = 88)

Ever Initiated
HPV
Vaccination
Total
N (%)
Yes
%
No
%
p-value
Total 33.0 67.1
Age 0.02
 18–26 28 (31.8) 50.0 50.0
 27–45 60 (68.2) 25.0 75.0
Gender 0.98a
 Cisgender man 68 (77.3) 35.3 64.7
 Cisgender woman 5 (5.7) 20.0 80.0
 Transgender man 1 (1.1) 0 100.0
 Transgender woman 6 (6.8) 33.3 66.7
 Non-binary 7 (8.0) 28.6 71.4
 Another gender 1 (1.1) 0 100.0
Sexual identity 0.17a
 Straight 5 (5.7) 0 100.0
 Gay/Lesbian 63 (71.6) 33.3 66.7
 Bisexual/Pansexual 17 (19.3) 47.1 52.9
 Another identity 3 (3.4) 0 100.0
Ethnoracial identity 0.90a
 White, non-Hispanic 46 (52.3) 34.8 65.2
 Black, non-Hispanic 14 (15.9) 28.6 71.4
 Hispanic/Latino 9 (10.2) 22.2 77.8
 Another/multiple identities 19 (21.6) 36.8 63.2
Health Insurance 0.67a
 Uninsured 4 (4.6) 25.0 75.0
 Public 30 (34.1) 26.7 73.3
 Private 54 (61.4) 37.0 63.0
Educational attainment 0.12
 High school 12 (14.0) 8.3 91.7
 Some college/vocation 23 (26.7) 34.8 65.2
 4-year college degree or higher 51 (59.3) 39.2 60.8
Medical home 0.76a
 No 15 (17.1) 26.7 73.3
 Yes 73 (83.0) 34.5 65.8
Medical home is at this FQHC 0.80
 No 35 (39.8) 31.4 68.6
 Yes 53 (60.2) 34.0 66.0
Currently taking PrEP 0.34
 No 17 (19.5) 23.5 76.5
 Yes 70 (80.5) 35.7 64.3
Past year HIV test 0.98a
 No 6 (6.8) 33.3 66.7
 Yes 82 (93.2) 32.9 67.1

Note. Row percentages are reported. Bolded p-values indicate p < 0.05

a

Fisher’s Exact Test